1. Home
  2. FOSL vs VTGN Comparison

FOSL vs VTGN Comparison

Compare FOSL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOSL
  • VTGN
  • Stock Information
  • Founded
  • FOSL 1984
  • VTGN 1998
  • Country
  • FOSL United States
  • VTGN United States
  • Employees
  • FOSL N/A
  • VTGN N/A
  • Industry
  • FOSL Consumer Specialties
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOSL Consumer Discretionary
  • VTGN Health Care
  • Exchange
  • FOSL Nasdaq
  • VTGN Nasdaq
  • Market Cap
  • FOSL 100.0M
  • VTGN 81.3M
  • IPO Year
  • FOSL 1993
  • VTGN N/A
  • Fundamental
  • Price
  • FOSL $1.76
  • VTGN $3.01
  • Analyst Decision
  • FOSL
  • VTGN
  • Analyst Count
  • FOSL 0
  • VTGN 0
  • Target Price
  • FOSL N/A
  • VTGN N/A
  • AVG Volume (30 Days)
  • FOSL 522.1K
  • VTGN 401.9K
  • Earning Date
  • FOSL 03-12-2025
  • VTGN 02-11-2025
  • Dividend Yield
  • FOSL N/A
  • VTGN N/A
  • EPS Growth
  • FOSL N/A
  • VTGN N/A
  • EPS
  • FOSL N/A
  • VTGN N/A
  • Revenue
  • FOSL $1,223,954,000.00
  • VTGN $876,000.00
  • Revenue This Year
  • FOSL N/A
  • VTGN N/A
  • Revenue Next Year
  • FOSL N/A
  • VTGN N/A
  • P/E Ratio
  • FOSL N/A
  • VTGN N/A
  • Revenue Growth
  • FOSL N/A
  • VTGN 8.08
  • 52 Week Low
  • FOSL $0.75
  • VTGN $2.22
  • 52 Week High
  • FOSL $2.61
  • VTGN $5.74
  • Technical
  • Relative Strength Index (RSI)
  • FOSL 49.72
  • VTGN 56.78
  • Support Level
  • FOSL $1.61
  • VTGN $2.85
  • Resistance Level
  • FOSL $1.97
  • VTGN $3.10
  • Average True Range (ATR)
  • FOSL 0.16
  • VTGN 0.21
  • MACD
  • FOSL -0.02
  • VTGN -0.00
  • Stochastic Oscillator
  • FOSL 35.71
  • VTGN 55.68

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: